89 related articles for article (PubMed ID: 18284183)
1. Unusual binding mode of the 2S4R stereoisomer of the potent aldose reductase cyclic imide inhibitor fidarestat (2S4S) in the 15 K crystal structure of the ternary complex refined at 0.78 A resolution: implications for the inhibition mechanism.
Zhao HT; Hazemann I; Mitschler A; Carbone V; Joachimiak A; Ginell S; Podjarny A; El-Kabbani O
J Med Chem; 2008 Mar; 51(5):1478-81. PubMed ID: 18284183
[TBL] [Abstract][Full Text] [Related]
2. High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor.
El-Kabbani O; Darmanin C; Oka M; Schulze-Briese C; Tomizaki T; Hazemann I; Mitschler A; Podjarny A
J Med Chem; 2004 Aug; 47(18):4530-7. PubMed ID: 15317464
[TBL] [Abstract][Full Text] [Related]
3. Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors.
El-Kabbani O; Darmanin C; Schneider TR; Hazemann I; Ruiz F; Oka M; Joachimiak A; Schulze-Briese C; Tomizaki T; Mitschler A; Podjarny A
Proteins; 2004 Jun; 55(4):805-13. PubMed ID: 15146479
[TBL] [Abstract][Full Text] [Related]
4. Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
El-Kabbani O; Carbone V; Darmanin C; Oka M; Mitschler A; Podjarny A; Schulze-Briese C; Chung RP
J Med Chem; 2005 Aug; 48(17):5536-42. PubMed ID: 16107153
[TBL] [Abstract][Full Text] [Related]
5. A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography.
Oka M; Matsumoto Y; Sugiyama S; Tsuruta N; Matsushima M
J Med Chem; 2000 Jun; 43(12):2479-83. PubMed ID: 10882376
[TBL] [Abstract][Full Text] [Related]
6. Factorizing selectivity determinants of inhibitor binding toward aldose and aldehyde reductases: structural and thermodynamic properties of the aldose reductase mutant Leu300Pro-fidarestat complex.
Petrova T; Steuber H; Hazemann I; Cousido-Siah A; Mitschler A; Chung R; Oka M; Klebe G; El-Kabbani O; Joachimiak A; Podjarny A
J Med Chem; 2005 Sep; 48(18):5659-65. PubMed ID: 16134934
[TBL] [Abstract][Full Text] [Related]
7. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
[TBL] [Abstract][Full Text] [Related]
8. Charge density and electrostatic interactions of fidarestat, an inhibitor of human aldose reductase.
Fournier B; Bendeif el-E; Guillot B; Podjarny A; Lecomte C; Jelsch C
J Am Chem Soc; 2009 Aug; 131(31):10929-41. PubMed ID: 19594152
[TBL] [Abstract][Full Text] [Related]
9. High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group.
Steuber H; Zentgraf M; Podjarny A; Heine A; Klebe G
J Mol Biol; 2006 Feb; 356(1):45-56. PubMed ID: 16337231
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a novel binding site conformer of aldose reductase in ligand-bound state.
Steuber H; Zentgraf M; La Motta C; Sartini S; Heine A; Klebe G
J Mol Biol; 2007 May; 369(1):186-97. PubMed ID: 17418233
[TBL] [Abstract][Full Text] [Related]
11. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
El-Kabbani O; Ramsland P; Darmanin C; Chung RP; Podjarny A
Proteins; 2003 Feb; 50(2):230-8. PubMed ID: 12486717
[TBL] [Abstract][Full Text] [Related]
12. Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
Carbone V; Giglio M; Chung R; Huyton T; Adams J; Maccari R; Ottana R; Hara A; El-Kabbani O
Eur J Med Chem; 2010 Mar; 45(3):1140-5. PubMed ID: 20036445
[TBL] [Abstract][Full Text] [Related]
13. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
El-Kabbani O; Old SE; Ginell SL; Carper DA
Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
[TBL] [Abstract][Full Text] [Related]
14. The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48.
Ruiz F; Hazemann I; Mitschler A; Joachimiak A; Schneider T; Karplus M; Podjarny A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1347-54. PubMed ID: 15272156
[TBL] [Abstract][Full Text] [Related]
15. Probing the ultra-high resolution structure of aldose reductase with molecular modelling and noncovalent mass spectrometry.
Darmanin C; Chevreux G; Potier N; Van Dorsselaer A; Hazemann I; Podjarny A; El-Kabbani O
Bioorg Med Chem; 2004 Jul; 12(14):3797-806. PubMed ID: 15210146
[TBL] [Abstract][Full Text] [Related]
16. Subatomic and atomic crystallographic studies of aldose reductase: implications for inhibitor binding.
Podjarny A; Cachau RE; Schneider T; Van Zandt M; Joachimiak A
Cell Mol Life Sci; 2004 Apr; 61(7-8):763-73. PubMed ID: 15095001
[TBL] [Abstract][Full Text] [Related]
17. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
Sotriffer CA; Krämer O; Klebe G
Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
[TBL] [Abstract][Full Text] [Related]
18. High-resolution neutron protein crystallography with radically small crystal volumes: application of perdeuteration to human aldose reductase.
Hazemann I; Dauvergne MT; Blakeley MP; Meilleur F; Haertlein M; Van Dorsselaer A; Mitschler A; Myles DA; Podjarny A
Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1413-7. PubMed ID: 16204895
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
Nakano T; Petrash JM
Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
[TBL] [Abstract][Full Text] [Related]
20. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.
Wang Z; Ling B; Zhang R; Suo Y; Liu Y; Yu Z; Liu C
J Mol Graph Model; 2009 Sep; 28(2):162-9. PubMed ID: 19616461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
